CN102038814A - Medicine for treating fracture - Google Patents
Medicine for treating fracture Download PDFInfo
- Publication number
- CN102038814A CN102038814A CN2010102912884A CN201010291288A CN102038814A CN 102038814 A CN102038814 A CN 102038814A CN 2010102912884 A CN2010102912884 A CN 2010102912884A CN 201010291288 A CN201010291288 A CN 201010291288A CN 102038814 A CN102038814 A CN 102038814A
- Authority
- CN
- China
- Prior art keywords
- medicine
- fracture
- treatment
- treating
- promoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a medicine for treating fracture, which is prepared from himalayan teasel root, ground beeltle, red flower, dragon's bone, dragon's blood, sappan wood, frank incense, myrrh, eucommia bark, cutch, acanthopanax bark and musk according to a certain ratio. The medicine has the effects of warming meridians and unblocking collaterals, relaxing muscle and tendon and setting fracture, and promoting blood circulation and removing blood stasis, can be used for treating the fracture and injuries from falls, fractures, contusions and strains, and has the characteristics of quick analgesia, short treatment course, good effect and low price.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of fracture, the Chinese medicine preparation of be particularly useful for fracturing, patient such as traumatic injury taking.
Background technology
Situations such as fracture, traumatic injury are multiple diseases, and asking it is middle old man's common frdquently encountered disease.The main situation such as people's falling down in motion or work that takes place, simultaneously along with the increase at people's age, the continuous loss of calcium forms osteoporosis in the human body, also very easily causes fracture.
The method that treatment is at present fractured mainly adopts operative treatment, and by proofreading and correct bone, planter cast is fixed, and smears Chinese and western drugses more for oral administration and thoroughly cures, and still often the course of treatment is long, and the expense height stays sequela easily.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of fracture, this medicine promoting the flow of QI in the collateral by warming the meridian, relieving rigidity of muscles and knitting bone, blood circulation promoting and blood stasis dispelling can play internal and external application to the treatment of miscellaneous fracture, traumatic injury, and muscles and bones is laid equal stress on, the purpose that therapeutic effect is good.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Radix Dipsaci 5~8 Eupolyphaga Seu Steleophagas 5~8
Flos Carthami 2~6 Os Draconis 5~8
Sanguis Draxonis 2~6 Lignum Sappans 4~8
Olibanum 2~6 Myrrhas 4~6
The Cortex Eucommiae 5~8 catechu 4~6
Cortex Acanthopancis 5~8 Moschus 2~4.
Said medicine can be made any dosage form on the pharmaceutics, as tablet, pill, powder, capsule etc., the preferred dosage form of the present invention is a powder.
The concrete preparation method of medicine of the present invention being made powder is:
Said medicine by described parts by weight mix homogeneously, is ground into 100~120 purpose medicated powder, and sterilization makes the powder product.
Fracture, the cause of disease is mainly the natural endowment deficiency, and the day after tomorrow is impairment caused by overstrain with the passing of time; Bone injury, myotility, skeletal diseases etc.After the Therapeutic Principle is the operation synthetism, use the medicine of promoting the flow of QI in the collateral by warming the meridian, relieving rigidity of muscles and knitting bone, blood circulation promoting and blood stasis dispelling, the treatment that muscles and bones is laid equal stress on.Radix Dipsaci tonifying liver, bone and muscle strengthening, decide meridians; Eupolyphaga Seu Steleophaga removing blood stasis, reunion of fractured tendons and bones; The Flos Carthami promoting blood circulation to restore menstrual flow, the blood stasis removing pain relieving; Os Draconis arresting sweating controlling nocturnal emission with astringent drugs, promoting tissue regeneration and ulcer healing; The analgesic therapy of Sanguis Draxonis dissipating blood stasis, hemostasia and promoting granulation; Lignum Sappan promoting the circulation of blood blood stasis dispelling, reducing swelling and alleviating pain, detumescence and promoting granulation; Myrrha promoting blood circulation and stopping pain, detumescence and promoting granulation; Cortex Eucommiae invigorating the liver and kidney, bone and muscle strengthening; Catechu removing dampness promoting tissue regeneration and ulcer healing; Cortex Acanthopancis invigorating the liver and kidney, bone and muscle strengthening, the arteries and veins of invigorating blood circulation; Moschus the meridian dredging, reducing swelling and alleviating pain.All medicines share, and promoting the flow of QI in the collateral by warming the meridian, relieving rigidity of muscles and knitting bone, blood circulation promoting and blood stasis dispelling are used for fracture, and the treatment of traumatic injury has that pain relieving is fast, a short treating period, effective, characteristics that the medicine valency is cheap.
For further investigating the clinical efficacy and the safety of medicine of the present invention, select 36 routine hyperosteogeny patients that the curative effect of medicine of the present invention has been carried out clinical observation.
36 routine cases are divided into two groups at random, every group 18 example.All case all is diagnosed as fracture according to diagnosis basis and typing in the fracture principle of diagnosis and treatment.
Therapeutic Method
Matched group adopts the conventional therapy with the auxiliary anti-inflammatory analgetic Western medicine of operation, and Western medicine is taken 2 times every day, each 3.The treatment group uses medicine of the present invention to treat after adopting the operation synthetism, takes every day 2 times, each 1 bag (3-5g).7 days is a course of treatment, takes 3 courses of treatment altogether.
Criterion of therapeutical effect
Medicine curative effect: effective: 2-3 days pain relieving, fracture line disappeared in 20-30 days; Effect is general: pain relieving in 6-7 days, and fracture line disappeared in 30-60 days; Weak effect: 7-15 days pain relieving, fracture line disappears more than 60 days.Two groups of case treatment back curative effect comparative results see Table 1.
Table 1 liang group case treatment back curative effect relatively
The specific embodiment
Embodiment 1
Get Radix Dipsaci 25g, Eupolyphaga Seu Steleophaga 25g, Flos Carthami 10g, Os Draconis 25g, Sanguis Draxonis 10g, Lignum Sappan 20g, Olibanum 10g, Myrrha 20g, Cortex Eucommiae 25g, catechu 20g, Cortex Acanthopancis 25g, Moschus 10g selected, that clear water is cleaned, make powder.
Embodiment 2
Get Radix Dipsaci 80g, Eupolyphaga Seu Steleophaga 60g, Flos Carthami 30g, Os Draconis 70g, Sanguis Draxonis 40g, Lignum Sappan 60g, Olibanum 50g, Myrrha 50g, Cortex Eucommiae 60g, catechu 40g, Cortex Acanthopancis 60g, Moschus 30g selected, that clear water is cleaned, make powder.
Claims (2)
1. medicine for the treatment of fracture is that feedstock production obtains by the Chinese medicine of following portions by weight:
Radix Dipsaci 5~8 Eupolyphaga Seu Steleophagas 5~8
Flos Carthami 2~6 Os Draconis 5~8
Sanguis Draxonis 2~6 Lignum Sappans 4~8
Olibanum 2~6 Myrrhas 4~6
The Cortex Eucommiae 5~8 catechu 4~6
Cortex Acanthopancis 5~8 Moschus 2~4.
2. the medicine of treatment fracture according to claim 1 is characterized in that described medicine is made powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102912884A CN102038814A (en) | 2010-09-19 | 2010-09-19 | Medicine for treating fracture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102912884A CN102038814A (en) | 2010-09-19 | 2010-09-19 | Medicine for treating fracture |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102038814A true CN102038814A (en) | 2011-05-04 |
Family
ID=43905576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102912884A Pending CN102038814A (en) | 2010-09-19 | 2010-09-19 | Medicine for treating fracture |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102038814A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111494578A (en) * | 2020-05-27 | 2020-08-07 | 苏雅拉图 | Mongolian medicine for promoting fracture healing and preparation method thereof |
-
2010
- 2010-09-19 CN CN2010102912884A patent/CN102038814A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111494578A (en) * | 2020-05-27 | 2020-08-07 | 苏雅拉图 | Mongolian medicine for promoting fracture healing and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102670928B (en) | Plaster for treating cervical spondylosis and lumbar spondylosis | |
CN101732521B (en) | Medicinal composition for treating fracture and preparation method thereof | |
CN102078391A (en) | Medicine for treating neck, shoulder, waist and leg pain | |
CN102895460B (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
CN104095953B (en) | A kind of medicated wine for the treatment of rheumatic osteopathia | |
CN103394031B (en) | Medicament for treating sciatica | |
CN103933129B (en) | Plaster for treating pain | |
CN102188572B (en) | Traditional Chinese drug for treating bone trauma | |
CN106728615A (en) | Chinese medicine composition for synthetism life bone and preparation method thereof | |
CN103495042A (en) | Traditional Chinese medicine composition for treating migraine | |
CN102600256A (en) | Traditional Chinese medical composition for treatment of traumatic injury | |
CN102274372B (en) | Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage | |
CN108175784A (en) | A kind of Chinese medicine composition of rheumatism treating and its medicament preparation method | |
CN100381147C (en) | Rapid-acting bone wound capsules and preparation thereof | |
CN102038814A (en) | Medicine for treating fracture | |
CN102078516B (en) | Traditional Chinese medicine for treating bone injury | |
CN109966451A (en) | A kind of Chinese medicine composition of bone-setting and pain-relieving | |
CN103157011B (en) | Traditional Chinese medicine composite for promoting fracture healing | |
CN108186995A (en) | Bone knitting plaster | |
CN1243565C (en) | Traditional Chinese medicine pain-relieving bag | |
CN102697928B (en) | Preparation method for medicine composition for treating traumatic injury | |
CN102018812A (en) | Qiqi straightening pill and preparation method thereof | |
CN100509052C (en) | Traditional Chinese medicine preparation for treating bone spinal cord inflammation | |
CN105560427A (en) | Transdermal gate-freeing powder | |
CN105617214A (en) | Traditional Chinese medicine composition for treating scabies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110504 |